Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Three Noble Metal Nanoparticles Demonstrated Distinct Biological Interactions and Cell Death Pathways in Human Hepatocarcinoma Cell Lines.

Nanotechnology, science and applications·2026
Same author

Developing a Tumor Microenvironment in Rotating Human Melanoma Cell Cultures: Study of a Novel Preclinical Model.

ACS omega·2025
Same author

Radiobioconjugate of Kadcyla with Radioactive Gold Nanoparticles for Targeted Therapy of HER2-Overexpressing Cancers.

Molecular pharmaceutics·2025
Same author

Cytotoxicity Comparison of <sup>99m</sup>Tc-Labeled Peptide Antagonist and Agonist Targeting the SSTR2 Receptor in AR42J Cells.

Molecules (Basel, Switzerland)·2025
Same author

Tailored Iron Oxide Nanoparticles as Potential Cannabinoid Carriers for Anti-Cancer Treatment.

Biomolecules·2025
Same author

Pt-Au Nanoparticles in Combination with Near-Infrared-Based Hyperthermia Increase the Temperature and Impact on the Viability and Immune Phenotype of Human Hepatocellular Carcinoma Cells.

International journal of molecular sciences·2025

Related Experiment Video

Updated: Dec 14, 2025

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

7.7K

Nanoparticles in Targeted Alpha Therapy.

Agnieszka Majkowska-Pilip1, Weronika Gawęda1, Kinga Żelechowska-Matysiak1

  • 1Centre of Radiochemistry and Nuclear Chemistry, Institute of Nuclear Chemistry and Technology, Dorodna 16, 03-195 Warsaw, Poland.

Nanomaterials (Basel, Switzerland)
|July 17, 2020
PubMed
Summary

Functional nanomaterials are advancing nuclear medicine, offering improved targeted alpha therapy. Nanoconstructs effectively immobilize alpha emitters for precise drug delivery, enhancing treatment outcomes.

Keywords:
nanomedicinenanoparticlesradiopharmaceuticalstargeted therapytumourα-emitters

More Related Videos

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

3.0K
Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
09:01

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

3.4K

Related Experiment Videos

Last Updated: Dec 14, 2025

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

7.7K
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

3.0K
Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
09:01

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

3.4K

Area of Science:

  • Nuclear Medicine
  • Nanotechnology
  • Radiopharmaceutical Chemistry

Background:

  • Nanotechnology applications in nuclear medicine show promise for enhanced therapeutic strategies.
  • Significant research focuses on nanoconstructs as carriers for alpha (α)-emitters in targeted drug delivery.
  • Functional nanomaterials are key for developing novel radiopharmaceuticals.

Purpose of the Study:

  • To provide a comprehensive overview of functional nanomaterials for targeted alpha therapy.
  • To explain the role of nanoconstructs in synthesizing α-emitting radiopharmaceuticals.
  • To discuss recent therapeutic applications and future prospects of radiolabeled nanomaterials.

Main Methods:

  • Literature review and synthesis of available information on functional nanomaterials.
  • Description of nanoconstruct synthesis for α-emitter immobilization.
  • Summarization of recent studies on α-emitting radiobioconjugates in targeted therapy.

Main Results:

  • Nanoconstructs serve as effective carriers for immobilizing alpha emitters.
  • Recent studies demonstrate therapeutic potential of α-emitting labeled radiobioconjugates.
  • Functional nanomaterials offer a promising platform for targeted alpha therapy.

Conclusions:

  • Nanomaterials are crucial for the development of targeted alpha therapy.
  • Nanoconstructs facilitate precise delivery of alpha emitters for improved treatment.
  • Future research holds potential for advanced therapeutic applications of radiolabeled nanomaterials.